$7.36
0.213.01%
Last update: 2:34 PM
15 minutes delayed
Comments
Loading...
BioCryst Pharma
BCRXNASDAQ
BioCryst Pharma (BCRX) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestBioCryst Pharma (NASDAQ:BCRX) Stock Quotes, Forecast and News Summary
BioCryst Pharma Stock (NASDAQ: BCRX) stock price, news, charts, stock research, profile.
| Open | $7.20 |
| Close | - |
| Volume / Avg. | 916.70K / 3.66M |
| Day Range | 7.12 - 7.36 |
| 52 Wk Range | 4.03 - 7.95 |
| Market Cap | $1.52B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 63 |
| Short Interest | 8.73% |
| Days to Cover | 4.03 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Biocryst Pharmaceuticals Inc.
Sector
Health Care
Industry
Biotechnology
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and developm...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy BioCryst Pharma (BCRX) stock?
You can purchase shares of BioCryst Pharma (NASDAQ:BCRX) through any online brokerage.
Who are BioCryst Pharma (BCRX) competitors?
Other companies in BioCryst Pharma’s space includes: Gyre Therapeutics (NASDAQ:GYRE), Immatics (NASDAQ:IMTX), Prothena Corp (NASDAQ:PRTA), Day One Biopharmaceutical (NASDAQ:DAWN) and Xencor (NASDAQ:XNCR).
What is the target price for BioCryst Pharma (BCRX) stock?
There is no analysis for BioCryst Pharma.
What is the forecast for BioCryst Pharma (BCRX) stock?
BioCryst Pharma has a consensus price target of $15.09.
Current stock price for BioCryst Pharma (BCRX)?
The stock price for BioCryst Pharma (NASDAQ: BCRX) is $7.355 last updated Today at July 22, 2024 at 2:34 PM EDT.
Does BioCryst Pharma (BCRX) pay a dividend?
There are no upcoming dividends for BioCryst Pharma.
When is BioCryst Pharma (NASDAQ:BCRX) reporting earnings?
BioCryst Pharma’s Q2 earnings are confirmed for Monday, August 5, 2024.
Is BioCryst Pharma (BCRX) going to split?
There is no upcoming split for BioCryst Pharma.
What sector and industry does BioCryst Pharma (BCRX) operate in?
BioCryst Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.